Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

Biotech stock GH Research catapulted Monday after the FDA gave it the go-ahead to resume testing its depression drug.

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

GH Research is scheduled to update on the FDA status of GH001 and outline its global Phase 3 plans for treatment-resistant ...

LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...

Depression is one of the most widespread health conditions in the world. According to the World Health Organization, it affects more than 280 million people globally, cutting across age, gender, and ...

A new study out of Stanford Medicine has found a “new category of depression” that impacts 27% of diagnosed individuals and is “not effectively” treated by standard antidepressants. Specifically, this ...

Let's go into some of the barriers to access for women who are suffering from postpartum depression. The barriers are multi. So I don't think that I can kind of even communicate all of them to you ...

Background Depression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor ...